Sage Mountain Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Sage Mountain Advisors's LLY Position: Q2 2026 in Review
Sage Mountain Advisors increased its Eli Lilly (LLY) stake by 43% in Q2 2026, buying an estimated $474K and bringing the position to 1,550 shares worth $1.86M. The position accounts for 0.11% of the portfolio, ranked #72.
Sage Mountain Advisors first reported a position in LLY in Q1 2021 and has held it in 22 quarters since. The position peaked at $7.66M in Q4 2025. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Sage Mountain Advisors held 1,550 shares of Eli Lilly worth $1.86M as of Q2 2026.
- Sage Mountain Advisors bought 464 Eli Lilly shares in Q2 2026, an estimated $474K.
- Eli Lilly made up 0.11% of Sage Mountain Advisors's portfolio in Q2 2026, its #72 holding.
- Sage Mountain Advisors first reported a position in Eli Lilly in Q1 2021 and has held it in 22 quarters since.
- Sage Mountain Advisors's Eli Lilly position peaked at $7.66M in Q4 2025.
- 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Sage Mountain Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.